Pramipexole Dihydrochloride Tablet, Extended Release
Product Images NDC 33342-211

Product Visual Gallery

This gallery contains 15 technical images submitted to the FDA as part of the official labeling for Pramipexole Dihydrochloride (NDC 33342-211). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Macleods Pharmaceuticals Limited, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Pramipexole 0375mg 100s

Pramipexole Dihydrochloride Extended-Release Tablets at 0.375 mg strength. No additional information available.*

FDA Label Image

Pramipexole 0375mg 30s

This is a prescription drug called Pramipexole in the form of Extended-Release Tablets. The recommended dosage is not mentioned, but it is clear that the tablets should be swallowed whole and not chewed, crushed, or divided. Each extended-release tablet contains 0.375 mg Pramipexole dihydrochloride. The drug should be stored between 20° to 25°C (68" to 77°F) and must be protected from exposure to high humidity, and kept out of reach of children. This drug is manufactured by Macleods Pharmaceuticals Ltd in India and distributed by Macleods Pharma USA Inc.*

FDA Label Image

Pramipexole 075mg 100s

FDA Label Image

Pramipexole 075mg 30s

This is a description of a medication called Pramipexole, manufactured by Macleods Pharma USA, Inc. It comes in the form of extended-release tablets and is used to treat symptoms of Parkinson's disease. The dosage is 0.75 mg and it should be swallowed whole and not chewed, crushed or divided. The tablets should be stored at 20° to 25°C and protected from exposure to high humidity. The medication is only available through prescription and comes with additional accompanying prescribing information.*

FDA Label Image

Pramipexole 1 5mg 100s

FDA Label Image

Pramipexole 15mg 30s

This is a medication for Pramipexole Dihydrochloride Extended-Release tablets, with a concentration of 1.5mg per tablet. It is only available in the original container and must be swallowed whole. The recommended storage temperature is between 20°C and 25°C, and it should not be exposed to high humidity. It is manufactured by Macleods Pharma USA, Inc., under the supervision of the USP Control Room Temperature guidelines. There is a warning to keep the medication out of children's reach.*

FDA Label Image

Pramipexole 225mg 100s

The text is a mixture of alphanumeric characters and does not form a coherent description, thus it is not available.*

FDA Label Image

Pramipexole 225mg 30s

This text is a prescribing information for dihydrochloride extended-release tablets of Pramipexole. The tablets should not be chewed, crushed, or divided, and should be stored between 20°C to 25°C. Each extended-release tablet contains 2.25 mg pramipexole dihydrochloride. The label specifies the unit of use container and the manufacturer of the drug. The text also contains some product details such as the NDC code of the drug, dosage, and storage information.*

FDA Label Image

Pramipexole 3 75mg 100s

FDA Label Image

Pramipexole 375mg 30s

Pharme NDC 3334221307 is a medication that comes in a container with 30 extended-release tablets. Each tablet contains 3.75 mg of pramipexole dihydrochloride monohydrate, which should not be chewed, crushed or divided. The tablets must be swallowed whole. The medication should be stored in a controlled room temperature, and protected from high humidity, and children. The manufacturer is Macleods Pharma USA, Inc., located in Plainsboro, NJ.*

FDA Label Image

Pramipexole 3mg 100s

FDA Label Image

Pramipexole 3mg 30s

This is a prescription drug with the NDC code 33342.21207 containing 3mg of Pramipexole dihydrochloride, USP. It is an extended-release tablet that is swallowed whole and should not be chewed, crushed or divided. The tablets should be stored at a temperature range of 20°C to 25°C with excursions permitted to 15°C to 30°C. This drug should be dispensed only in the original USP controlled room temperature unit of use container. Macleods Pharma USA, Inc. is the manufacturer and it is manufactured by Macleods Pharmaceuticals Lid.*

FDA Label Image

Pramipexole 4 5mg 100s

FDA Label Image

Pramipexole 45mg 30s

This is a prescription drug with the NDC code 3334221407. It contains 4.5mg Pramipexole Dihydrochloride equivalent to 4.23mg Pramipexole. The tablets must be swallowed whole and should not be chewed, crushed, or divided. They must be stored within the temperature range of 20°C to 25°C (68°F to 77°F) and protected from exposure to high humidity. The medication is manufactured by Macleods Pharma USA, Inc. and distributed in a unit of use container with 30 tablets.*

FDA Label Image

Prami (Pramipexole Structural Formula)

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.